R. Hoffman
Biophysics · Cell · 2002–2011
A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 11 researchers here, as inferred from the citation graph.
Subfields
- Biophysics — 5 citations into it; #264 of 1,196 by trust here, #996 by citations
Whom R. Hoffman trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts R. Hoffman overall
Papers from R. Hoffman's perspective
Ordered by how strongly the researchers R. Hoffman trusts endorse each paper. Same corpus, a different order for every researcher.
- Apoptosis A Link between Cancer Genetics and Chemotherapy (Cell)
- Cellular senescence as a tumor-suppressor mechanism. (Trends in Cell Biology)
- The INK4a/ARF network in tumour suppression (Nature reviews. Molecular cell biology)
- A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. (Cell)
- Tumor imaging by means of proteolytic activation of cell-penetrating peptides. (Proceedings of the National Academy of Sciences of the United States of America)
- Dissecting tumour pathophysiology using intravital microscopy (Nature Reviews. Cancer)
- Openings between defective endothelial cells explain tumor vessel leakiness. (American Journal of Pathology)
- Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. (New England Journal of Medicine)
- Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. (Cancer Cell)
- Origins of circulating endothelial cells and endothelial outgrowth from blood. (Journal of Clinical Investigation)
Their papers
- Fibroblast-recruited, tumor-infiltrating CD4+ T cells stimulate mammary cancer metastasis through RANKL-RANK signaling (2011) — 637 citations
- Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. (2010) — 776 citations
- The multiple uses of fluorescent proteins to visualize cancer in vivo (2005) — 631 citations
- A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. (2002) — 1,074 citations